In vitro activities of cefepime alone and with amikacin against aminoglycoside-resistant gram-negative bacteria.
AUTOR(ES)
Fung-Tomc, J
RESUMO
The in vitro activity of cefepime was compared with those of ceftazidime, cefotaxime, and cefpirome against aminoglycoside-resistant gram-negative bacteria. Cefepime was the most active cephalosporin, with a MIC for 90% of strains tested for all non-Pseudomonas aeruginosa species of less than or equal to 4 micrograms/ml. No cefepime resistance was encountered among members of the family Enterobacteriaceae. Of the 40 aminoglycoside-resistant P. aeruginosa isolates, 15% were resistant to cefepime, compared with 18% for ceftazidime, 30% for cefpirome, and 35% for cefotaxime. Synergism between cefepime and amikacin was observed and occurred most frequently in P. aeruginosa strains resistant to cefepime but susceptible to amikacin. In no case did cefepime and amikacin exhibit antagonism against P. aeruginosa.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=245450Documentos Relacionados
- Aminoglycoside-resistant gram-negative bacilli in a community hospital: comparative in vitro activity of cefotaxime, moxalactam, cefoperazone, and piperacillin.
- In vitro activities of enoxacin and 17 other antimicrobial agents against multiply resistant, gram-negative bacteria.
- In vitro activity of ciprofloxacin against aerobic gram-negative bacteria.
- Amifloxacin activity against well-defined gentamicin-resistant, gram-negative bacteria.
- In vitro activity of biapenem against clinical isolates of gram-positive and gram-negative bacteria.
